GRANTS
-
To be updated
PROJECT TITLE PI DURATION AMOUNT GRANTS 1. 2. 3. -
To be updated
PROJECT TITLE PI DURATION AMOUNT GRANTS 1. 2. 3. -
RESEARCH GRANTS secured in 2021
PROJECT TITLE PI DURATION AMOUNT GRANTS 1. PROTEOMICS ANALYSIS OF MULTIPLE MYELOMA CELL LINES INDUCED BY EPIGENETIC REGULATORS AND HISTONE DEACETYLASE INHIBITORS ASSOC. PROF. DR. MUHAMMAD FARID JOHAN 1 JULY 2021 - 30 JUNE 2023 RM10,000.00 GERAN INSENTIF PEMBANGUNAN SISWAZAH- PhD (GIPS-PhD) -
RESEARCH GRANTS secured in 2020
TitlePIDuration AMOUNT GRANTS 1Haemostatic, Inflammatory and haematological Biomarkers among Surgical Based patients (Orthopaedics and Surgery) with Prolonged Immobilization and risk of Venous Thromboembolism. Dr Salfarina Iberahim 1 Aug 2020 - 31 July 2022
RM34,020.00 USM Short Term 2 The Role of Thalassemic Red Cell in the Mechanism Process of Hypercoagulable State in Thalassemia Intermedia and Major Patient PROFESOR MADYA DR. ROSNAH BINTI BAHAR 1 Nov 2020 - 31 Oct 2023 RM42,000.00 RUI 3 Investigating and understanding the genetic (HLA, immunoregulatory genes, cytokine gene) and immunomodulatory factor of RBC alloimmunization in the pregnant woman
Dr. Mohd Nazri Bin Hassan
1 Nov 2020 - 31 Oct 2023 RM151,308.00
FRGS -
RESEARCH GRANTS secured in 2019NATIONAL GRANTSTitlePIDurationAMOUNTGrants1.
Investigating and understanding the genetic risk factors (cytokine, MHC, KIR, TLR, IgG receptor, platelet glycoprotein, MBL and immunoglobulin genes) of immune thrombocytopenic purpura (ITP): towards a novel strategy for diagnosis and management of ITP Assoc. Prof. Dr. Noor Haslina Mohd Noor 1 Sept 2019 - 31 Aug 2022159,268.00FRGS2.The immunoregulation of high dose Vitamin C and low dose chemotherapy (HiCLoChemo) as a novel cancer chemoimmunotherapeutic in breast cancer rats model Prof. Dr. Rosline Hassan 1 Sept 2019 - 31 Aug 2022181,700.00FRGS3. Elucidating the genetic basis of Xmn1-HBG2 and HBS1L-MYB single nucleotide polymorphisms (SNPs) in controlling the hemoglobin F (HbF) level in patient with acquired anemia. Dr. Zefarina Zulkafli 1 Sept 2019 -30 Nov 2022 106,530.00 FRGS UNIVERSITY GRANTS
TitlePIDurationAMOUNTGrants1.Detection of minimal residual disease using flor cytometry in acute lymphoblastic leukaemiaDr. Shafini Mohamed YusoffAug 2019 - July 202023,472.00Bridging2.3. -
RESEARCH GRANTS secured in 2018NATIONAL GRANTSTitlePIDurationAMOUNTGrants1.
Elucidating the role of DNA methylation as modifiers of beta-globin gene in HbE/Beta Thalassaemia via an in-vitro model of epigenetic expression system
Assoc. Prof. Dr. Muhammad Farid Johan1 Jan 2019 - 30 Sept 2022180,800.00FRGS2.3. UNIVERSITY GRANTS
TitlePIDurationAMOUNTGrants1.ELUCIDATING THE ROLE OF TUBB2A, CCNA1 AND SOCS3 DOWN-REGULATION IN ACUTE MYELOID LEUKEMIA (AML) CELL LINES TREATED WITH DNA METHYLTRANSFERASE AND HISTONE DEACETYLASE INHIBITORS Assoc. Prof. Dr. Muhammad Farid JohanJan 2018 - Jan 201910,000.00Bridging2.RED CELL ALLO AND AUTOIMMUNIZATION IN CANCER PATIENTS AT HOSPITAL UNIVERSITI SAINS MALAYSIADr Mohd Nazri Bin HassanAug 2018-May 202132,955.30USM Short term3. -
RESEARCH GRANTS secured in 2017NATIONAL GRANTSTitlePIDurationAMOUNTGrants1.2.
3. UNIVERSITY GRANTS
TitlePIDurationAMOUNTGrants1.THE DEVELOPMENT OF NOVEL BACULOVIRUS INSECTICIDE EXPRESSING MULTIPLE INSECTICIDAL PROTEIN FROM THE NATURAL ENEMIES OF RED PALM WEEVIL (Rhynchophorus ferrugineus)
Assoc. Prof. Dr. Muhammad Farid JohanNov 2017 - July 202193,106.00RU2.PROTEIN EXPRESSION OF EPIGENETICALLY RE-EXPRESSED GENES INDUCED BY TRICHOSTATIN A AND 5-AZACYTIDINE TREATMENTS IN ACUTE MYELOID LEUKEMIC CELL LINES Assoc. Prof. Dr. Muhammad Farid JohanAug 2017 - Oct 20172,950.00Incentive3. Understanding the Apoptotic Effects of Epigenetic Modification Drugs on Proteome Profiles of Myeloid and Lymphoid Cell Lines Assoc. Prof. Dr. Muhammad Farid Johan Aug 2017 - Oct 2017 2,950.00 Incentive 4. DNA Methylation of IGSF4 and LARP2 genes as Epigenetic Modifiers in HbE/β Thalassemia Phenotypic Heterogeneity
Assoc. Prof. Dr. Muhammad Farid Johan Aug 2017 - Oct 2017 3,000.00 Incentive -
RESEARCH GRANTS secured in 2016
UNIVERSITY GRANTS
TitlePIDurationAMOUNTGrants1.Genetic identification Aberration in Normal cytogenetic AML and Biological Parameters stupa WITH ClinicoDr Marini RamliMac 2016 - Feb 2020RM178,000.00RUi -
RESEARCH GRANTS secured in 2015
NATIONAL GRANTS
TitlePIDurationAMOUNTGrants1.Impact on the Environment Assets: Nutrition and elucidating the immunological factors as contributing to the health status of the local election in Kelantan Flood VictimsProf Dr Rosline HassanApr 2015 - Mac 2016RM137,200.00KPTUNIVERSITY GRANTS
TitlePIDurationAMOUNTGrants1.Instead of elucidating the mechanism of ineffective erythropoiesis Contributes to Disease Severity In Beta ThalassemiaProf Dr Rosline HassanJuly 2015 - June 2017RM142,404.00Rui2.A Pilot Study in laboratory and clinical features of Rare Anti-phospholipid antibodies in pre-eclampsia patients, USMDr Wan Mahmood Wan HaslindawaniJun 2015 - Mei 2017RM46,920.00USM Short Term -
RESEARCH GRANTS secured in 2014NATIONAL GRANTSTitlePIDurationAMOUNTGrants1.Ineffective erythropoiesis understand that the transfer of liability thalassemia; Role AHSP and telomere length factor ContributionsProf Dr Rosline HassanDis 2014 - Nov 2016RM130,000.00FRGS2.Mechanism of Action Under current regulator JAK / STAT signaling pathway in Flt3-ITD-resistant cells Acute myeloid leukemia, the Ministry of Education MalaysiaDr Muhammad Farid JohanAugust 2014 - December 2016RM124,526.00FRGS
UNIVERSITY GRANTS
TitlePIDurationAMOUNTGrants1.Monocytes and lymphocytes AS EX new hematological markers To detect Dengue feverDr Shafini Mohamed YusoffAugust 2014 - August 2016USM Short Term2.Factors contributing to the success of Autologous Peripheral Blood Stem Cell Transplantation In lymphoproliferative disease at Hospital Universiti Sains MalaysiaDr Mohd Nazri HassanSeptember 2014 - August 2016RM38,335.00USM Short Term3.In the assessment of capillary electrophoresis to detect Hemoglobin E Among neonates in the hospital SentAssoc. Prof Dr Rosnah BaharDec 2014 - December 2016RM40,000.00USM Short Term4.Evaluation of immune markers and haemostatic Among the most frequent Whole Blood DonorsAssoc. Prof. Dr Rapiaah MustaffaNovember 2014 - November 2016RM39,740.00USM Short Term5.A Pilot Study on Clinical and Laboratory Profile Blood Donor WITH erythrocytosisAssoc. Prof. Dr Mohd Noor Noor HaslinaSeptember 2014 - August 2016RM43,813.00USM Short Term -
RESEARCH GRANTS secured in 2009-2013
NATIONAL/UNIVERSITY GRANTS
TitlePIDurationAMOUNTGrants1.Development of In Vitro Whole Blood (WB) Clot Method To Study fibrinolytic activity and haemostatic Properties Of Pure caffeic acid phenethyl ester (CAPE) Compound Propolis And LocalProf Dr Wan Zaidah Abdullah2013 - 2016USM RU2. Identification of Differentially Expressed Genes & Epigenetic Inactivation Profiling of Various Cytogenetic Rearragements in Primary AML cell lines
Dr Muhammad Farid Johan Nov 2011 - Nov 2014 240,662.25 USM RU 3. In Vitro Study of Mechanism of Resistance to Tyrosine Kinase Inhibitors in Leukaemia: Effects on Methylation in JAK/STAT Signalling Pathway Dr Muhammad Farid Johan Mar 2010 - Feb 2012 40,000.00 USM Short Term 4. EFFECTS OF MALAYSIAN RED EDIBLE PLANTS AS ANTI CANCER THERAPY ON RTK/RAS SIGNALLING PATHWAY IN LEUKAEMIC CELL LINES Dr Muhammad Farid Johan Dec 2009 - Dec 2011 50,000.00 FRGS